{"id":"W4210274145","doi":"10.1016/j.ygyno.2022.01.024","title":"Efficacy and safety of olaparib according to age in BRCA1/2-mutated patients with recurrent platinum-sensitive ovarian cancer: Analysis of the phase III SOLO2/ENGOT-Ov21 study","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Olaparib; Medicine; Tolerability; Hazard ratio; Internal medicine; Oncology; Discontinuation; Placebo; Ovarian cancer; Cohort; PARP inhibitor; Confidence interval; Cancer; Adverse effect; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001717779,0.0007418473,0.00181959,0.0004706994,0.0002317799,0.000989724,0.000530723,0.0008057446,0.0009522008],"category_scores_gemma":[0.002067531,0.000329958,0.001542932,0.0005513463,0.0005899564,0.0009910743,0.0003881706,0.001667142,0.0002069021],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006750022,"about_ca_system_score_gemma":0.0004874014,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004434701,"about_ca_topic_score_gemma":0.00122887,"domain_scores_codex":[0.9991931,0.0004215659,0.00005148057,0.0001586557,0.00008517583,0.00009008741],"domain_scores_gemma":[0.9988323,0.000399829,0.000310977,0.0001306049,0.0000408557,0.0002853868],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7250899,0.00480046,0.1007356,0.0005342998,0.004809375,0.0001521046,0.0002475819,0.003730359,0.01196059,0.0002279266,0.001644493,0.1460674],"study_design_scores_gemma":[0.3472977,0.2128382,0.4133249,0.0001774066,0.006018548,0.0008941785,0.0002569287,0.006866836,0.004726978,0.001704643,0.005696005,0.0001977201],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994315,0.00411094,0.0001802456,0.0001765777,0.00003606149,0.00009671618,0.0004943075,0.00002309118,0.0005670956],"genre_scores_gemma":[0.9968261,0.001332128,0.0002823767,0.0002993866,0.00005611901,0.00007913551,0.0007808429,0.00001516725,0.0003289615],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00181959,"threshold_uncertainty_score":0.009084582,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0263865775349412,"score_gpt":0.3524282690015788,"score_spread":0.3260416914666376,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}